Consistent with the importance of TRAF3 in B cell biology, deletions and inactivating mutations of the TRAF3 gene were first reported in human multiple myeloma (MM) (9, 10), a malignancy derived from plasma cells. The gene discussed is TRAF3; the disease is plasma cell myeloma.